Antibiotic study for fever after cancer treatment
Part of Blood & lymphatic, Cancer clinical trials.
This trial tests a better way to use antibiotics for cancer patients who develop a fever after treatment. It aims to improve care and reduce side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You had a fever of at least 100.9°F (38.3°C) within the past 24 hours before arriving at the emergency room.
- You received chemotherapy or targeted therapy for a solid tumor within the last 6 weeks.
- You are being treated for leukemia, lymphoma, myelodysplastic syndrome, aplastic anemia, multiple myeloma, or you have had a stem cell transplant.
- You are willing and able to give permission for the study team to access your medical records.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two antibiotics, ciprofloxacin and ceftazidime, to see which works better for treating fever in children with blood cancer who have a high risk of infection due to low white blood cells. The goal is to find the best treatment to help your child recover faster.
This study tests a new medicine called Telpegfilgrastim to help prevent fever from low white blood cell counts in children (14–17) with certain cancers who are getting strong chemotherapy. It aims to see if the medicine is safe and works well.
This trial compares stopping antibiotics early (after fever resolves) versus continuing them as usual in adults with blood cancers who develop fever during treatment. It aims to find the best timing to reduce unnecessary antibiotic use.
This study looks at how long antibiotics should be given to cancer patients with fever and very low white blood cell counts after finding a certain type of bacteria (Gram-negative) in their blood. The goal is to find the best treatment duration to help patients recover without complications.
This study tests whether it's safe to stop antibiotics early in patients who have had a fever while their immune system is weak from chemotherapy. If you've been fever-free for 48 hours, you may be able to avoid unnecessary antibiotics.
This trial tests whether an antibiotic called ceftazidime-avibactam (CAZ-AVI) can help patients with blood cancers who have a fever and very low infection-fighting white blood cells. It may be an option for people whose doctors plan to use this specific antibiotic to treat their fever.
Hear when a new Neutropenic Fever trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.